ZS Pharma Company Profile (NASDAQ:ZSPH)

About ZS Pharma

ZS Pharma logoZS Pharma, Inc. is a biopharmaceutical company focused on the development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. The Company's zirconium silicate technology allows it to create selective ion traps that can reduce toxic levels of specific electrolytes without disturbing the balance of other electrolytes. The Company has completed Phase III development of its product candidate, sodium zirconium cyclosilicate (ZS-9), for the treatment of hyperkalemia, a life-threatening condition in which elevated levels of potassium increase the risk of muscle dysfunction, including cardiac arrhythmias and sudden cardiac death. The Company has completed three clinical studies with ZS-9 for patients with hyperkalemia, including patients with chronic kidney disease (CKD), heart failure (HF), diabetes and those on renin-angiotensin aldosterone system (RAAS) inhibitor therapy.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ZSPH
  • CUSIP:
Key Metrics:
  • Previous Close: $89.98
  • 50 Day Moving Average: $85.57
  • 200 Day Moving Average: $66.48
  • 52-Week Range: $37.52 - $91.24
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -17.71
  • P/E Growth: 0.00
  • Market Cap: $N/A
Additional Links:
Companies Related to ZS Pharma:

Analyst Ratings

Consensus Ratings for ZS Pharma (NASDAQ:ZSPH) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for ZS Pharma (NASDAQ:ZSPH)
Show:
DateFirmActionRatingPrice TargetDetails
11/18/2015Citigroup Inc.DowngradeBuy -> Neutral$90.00View Rating Details
11/9/2015J P Morgan Chase & CoDowngradeOverweight -> Neutral$75.00 -> $90.00View Rating Details
11/9/2015Morgan StanleyDowngradeOverweight -> Equal Weight$79.00 -> $90.00View Rating Details
11/9/2015Credit Suisse GroupDowngradeOutperform -> Neutral$67.00 -> $90.00View Rating Details
11/6/2015William BlairDowngradeOutperform -> Market PerformView Rating Details
9/11/2015BMO Capital MarketsReiterated RatingBuy$70.00 -> $83.00View Rating Details
(Data available from 2/24/2015 forward)

Earnings

Earnings History for ZS Pharma (NASDAQ:ZSPH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2015Q315($1.04)($0.41)ViewN/AView Earnings Details
8/6/2015($0.90)($1.30)ViewN/AView Earnings Details
5/11/2015Q115($0.86)($1.05)ViewN/AView Earnings Details
3/13/2015Q414($0.75)($0.98)ViewN/AView Earnings Details
11/10/2014Q314($0.74)($0.81)ViewN/AView Earnings Details
8/14/2014Q214($0.66)($4.72)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for ZS Pharma (NASDAQ:ZSPH)
Current Year EPS Consensus Estimate: $-4.68 EPS
Next Year EPS Consensus Estimate: $-5.08 EPS

Dividends

Dividend History for ZS Pharma (NASDAQ:ZSPH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for ZS Pharma (NASDAQ:ZSPH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/21/2015Todd A. CreechCFOSell70,000$49.84$3,488,800.00View SEC Filing  
6/8/2015Alta Partners Viii, L.P.Major ShareholderSell175,427$57.86$10,150,206.22View SEC Filing  
6/4/2015Alta Partners Viii, L.P.Major ShareholderSell111,597$57.30$6,394,508.10View SEC Filing  
6/2/2015Alta Partners Viii, L.P.Major ShareholderSell296,423$58.00$17,192,534.00View SEC Filing  
6/23/2014A/S NovoInsiderBuy275,000$18.00$4,950,000.00View SEC Filing  
6/23/2014Guy P NohraDirectorBuy200,000$18.00$3,600,000.00View SEC Filing  
6/23/2014Park Bioventures Lp DevonMajor ShareholderBuy160,000$18.00$2,880,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for ZS Pharma (NASDAQ:ZSPH)
DateHeadline
News IconWill The Needle Move For ZS Pharma, Inc. (NASDAQ:ZSPH) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:ZSPH)
wsbeacon.com - January 16 at 9:54 PM
News IconPlacing ZS Pharma, Inc. (NASDAQ:ZSPH) Shares Under the Microscope - National Daily Press (NASDAQ:ZSPH)
www.nationaldailypress.com - September 10 at 5:13 AM
News IconZS Pharma, Inc. (NASDAQ:ZSPH) From The Analysts Point of View - National Daily Press (NASDAQ:ZSPH)
www.nationaldailypress.com - September 8 at 7:52 PM
seekingalpha.com logoWhat To Do With Your Relypsa Winnings - Seeking Alpha (NASDAQ:ZSPH)
seekingalpha.com - July 22 at 8:14 PM
smarteranalyst.com logoHC Wainwright Weighs In On Two Healthcare Stocks: Relypsa Inc (RLYP) and Biogen Inc (BIIB) - Smarter Analyst (NASDAQ:ZSPH)
www.smarteranalyst.com - July 22 at 8:14 PM
investors.com logoBid war beckons after Galenica snaps up Relypsa, brokers say - Proactive Investors USA & Canada (NASDAQ:ZSPH)
www.proactiveinvestors.com - July 21 at 11:18 AM
fool.com logoShares Of Relypsa Inc. Are Surging Again -- Here's Why (NASDAQ:ZSPH)
www.fool.com - May 27 at 11:42 AM
bloomberg.com logoAstraZeneca's Good Deal Turns Bad (NASDAQ:ZSPH)
www.bloomberg.com - May 27 at 11:40 AM
finance.yahoo.com logoAstraZeneca Remains Committed To Development Of ZS-9 Despite Letter From FDA (NASDAQ:ZSPH)
finance.yahoo.com - May 27 at 7:47 AM
uk.finance.yahoo.com logoQuestor share tip: AstraZeneca faces Crestor crunch in year ahead (NASDAQ:ZSPH)
uk.finance.yahoo.com - February 5 at 3:59 AM
gurufocus.com logoThe Gabelli ABC Fund Merger and Arbitrage Shareholder Commentary for Q4 (NASDAQ:ZSPH)
www.gurufocus.com - January 29 at 12:53 PM
investornewswire.com logoZS Pharma, Inc. (NASDAQ:ZSPH) - Stock Sentiment And ABR Update - Investor Newswire (NASDAQ:ZSPH)
www.investornewswire.com - January 22 at 7:06 PM
finance.yahoo.com logoActelion says selexipag to enter U.S. market in January (NASDAQ:ZSPH)
finance.yahoo.com - December 22 at 1:32 AM
noodls.com logoAstraZeneca completes acquisition of ZS Pharma (NASDAQ:ZSPH)
www.noodls.com - December 21 at 7:08 PM
moodys.com logoAstraZeneca PLC -- Moody's downgrades AstraZeneca to A3, stable outlook (NASDAQ:ZSPH)
www.moodys.com - December 18 at 12:47 PM
biz.yahoo.com logoZS PHARMA, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failur (NASDAQ:ZSPH)
biz.yahoo.com - December 17 at 5:07 PM
sg.finance.yahoo.com logoAstraZeneca buys most of Acerta for $4 billion to add cancer drug (NASDAQ:ZSPH)
sg.finance.yahoo.com - December 17 at 11:09 AM
bizjournals.com logoAstraZeneca confirms interest in a possible $5B purchase (NASDAQ:ZSPH)
www.bizjournals.com - December 14 at 9:30 AM
finance.yahoo.com logoZS PHARMA, INC. Financials (NASDAQ:ZSPH)
finance.yahoo.com - December 8 at 1:17 PM
investors.com logoRelypsa Stock Jumps On Buyout Rumors (NASDAQ:ZSPH)
news.investors.com - December 4 at 3:31 PM
insidermonkey.com logoZS Pharma Inc (ZSPH) Generating Strong Interest from Top Money Managers (NASDAQ:ZSPH)
www.insidermonkey.com - December 2 at 3:44 PM
insidermonkey.com logoAre Hedge Funds Dumping Amicus Therapeutics, Inc. (FOLD)? (NASDAQ:ZSPH)
www.insidermonkey.com - November 25 at 2:19 PM
insidermonkey.com logoHedge Fund Sentiment Has This to Say About These Moves on 3 Healthcare Stocks (NASDAQ:ZSPH)
www.insidermonkey.com - November 20 at 11:57 AM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ZS Pharma, Inc. of Commencement of an Investigation In Connection With the Fairness of the Sale of the Company to AstraZeneca PLC -- ZSPH (NASDAQ:ZSPH)
finance.yahoo.com - November 13 at 12:49 PM

Social

What is ZS Pharma's stock symbol?

ZS Pharma trades on the NASDAQ under the ticker symbol "ZSPH."

How do I buy ZS Pharma stock?

Shares of ZS Pharma can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of ZS Pharma stock cost?

One share of ZS Pharma stock can currently be purchased for approximately $89.98.

ZS Pharma (NASDAQ:ZSPH) Chart for Friday, February, 24, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for ZS Pharma (NASDAQ:ZSPH)

Earnings History Chart

Earnings by Quarter for ZS Pharma (NASDAQ:ZSPH)

Dividend History Chart

Dividend Payments by Quarter for ZS Pharma (NASDAQ:ZSPH)

Last Updated on 2/24/2017 by MarketBeat.com Staff